UK Drug Company AstraZeneca (AZN) With a Stock Market Cap of US$88 Bil Had 34% of Its 2016 Total Revenues Made To US Customers and a Much Higher 47% of Its 2016 Total Property, Plant and Equipment, the Main Drivers of the Coveted US Deferred Income Tax Liabilities (DTLs), Located in the US
From AZN's US SEC Filings